SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Holding(s) in Company

28 Oct 2009 17:40

RNS Number : 5504B
Rentokil Initial PLC
28 October 2009
Β 

ο»Ώ

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuerΒ of existing shares to which voting rights areΒ attached:

Rentokil Initial plc

2 Reason for the notificationΒ (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

 √

An acquisition or disposal ofΒ qualifyingΒ financial instruments which may result in theΒ acquisition of shares already issuedΒ to which voting rights are attached

Β 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

Β 

An event changing the breakdown of voting rights

Β 

Other (please specify):

Β 

3. Full name of person(s) subject to theΒ notification obligation:

Β 

Invesco Limted

4. Full name of shareholder(s)Β (if differentΒ from 3.):

Β 

As above

5. Date of the transaction and date onΒ which the threshold is crossed orΒ reached:

23 October 2009

6.Β Date on which issuer notified:

26 October 2009

7. Threshold(s) that is/are crossed orΒ reached:

9%, 5%, 4%

Β Β 

8. Notified details:

A: Voting rights attached to shares

Class/type of shares

if possible using the ISIN CODE

Situation previous to theΒ triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

Ordinary

GB00B082RF11

180,932,303

180,932,303

-

-

90,418,270

-

4.98%

Β 

B:Β QualifyingΒ Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/Β ConversionΒ Period

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

Β N/a

Β 

Β 

Β 

Β 

C:Β FinancialΒ Instruments with similar economic effect to QualifyingΒ FinancialΒ Instruments

Resulting situation after the triggering transaction

Type of financial instrument

ExerciseΒ price

ExpirationΒ date

Exercise/ ConversionΒ period

Number of votingΒ rights instrumentΒ refers to

% of voting rights

Β N/a

Β 

Β 

Β 

Β 

Nominal

Delta

Β 

Β 

Total (A+B+C)

Number of voting rights

PercentageΒ of voting rights

90,418,270

4.98%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

Brown Brothers HarrimanΒ New JerseyΒ  956,451

Bank of Irelan Dublin 4,401,067

Bank ofΒ New York 54,017,790

Banque Paribas Β  Β 1,337,117

Bank ofΒ New YorkΒ Frankfurt Β 121,142

Bank ofΒ New YorkΒ Brussels 367,627

Bank ofΒ New YorkΒ Singapore 342,338

BostonΒ Safe Deposit 567,653

Chase Bank 1,121,190

JP Morgan Chase 6,319,016

CitibankΒ New York 52,238

Morgan StanleyΒ London 83,721

State StreetΒ Sydney 37,272

State Street Trust & Banking Co 19,950,000

Trust & Custody Services JP 49,354

Northern Trust CompanyΒ London 500,000

Invesco PowerShares Capital Management 173,706

Invesco PowerShares Capital Management Ireland Ltd 20,588

Proxy Voting:

10. Name of the proxy holder:

Β N/a

11. Number of voting rights proxy holder will ceaseΒ to hold:

Β 

12. Date on which proxy holder will cease to holdΒ voting rights:

Β 

13. Additional information:

Samantha Edwards at Invesco - 01491 416381

14. Contact name:

Paul Griffiths

Company Secretary

Rentokil Initial plc

15. Contact telephone number:

01293 858000

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
HOLUWOBRKBRRUAA
Date   Source Headline
21st May 20267:00 amRNSAppointment of CEO, North America
8th May 202610:30 amRNSHolding(s) in Company
7th May 20264:40 pmRNSResult of AGM
23rd Apr 20264:25 pmRNSFinal Dividend – Pence Sterling Amount Payable
23rd Apr 20262:30 pmRNSIssuance of $500 million 4.625% Notes due 2031
21st Apr 202610:30 amRNSHolding(s) in Company
16th Apr 20267:00 amRNSQ1 Trading Update
15th Apr 20267:00 amRNSDirectorate Change
30th Mar 202610:30 amRNSHolding(s) in Company
26th Mar 20263:46 pmRNSDirector/PDMR Shareholding
25th Mar 202610:50 amRNSAnnual Financial Report
17th Mar 20264:30 pmRNSDirector/PDMR Shareholding
16th Mar 202610:32 amRNSHolding(s) in Company
16th Mar 202610:32 amRNSHolding(s) in Company
12th Mar 202610:30 amRNSHolding(s) in Company
10th Mar 20264:28 pmRNSDirector/PDMR Shareholding
10th Mar 20264:28 pmRNSDirector/PDMR Shareholding
10th Mar 20264:26 pmRNSDirector/PDMR Shareholding
10th Mar 20264:26 pmRNSDirector/PDMR Shareholding
9th Mar 202611:15 amRNSHolding(s) in Company
5th Mar 20267:00 amRNSPreliminary Results
5th Mar 20267:00 amRNSChair Succession Planning Update
23rd Feb 202610:30 amRNSHolding(s) in Company
19th Feb 20262:50 pmRNSDirector Declaration
12th Feb 20265:30 pmRNSNotice of Early Redemption
20th Jan 202610:25 amRNSHolding(s) in Company
19th Jan 202610:30 amRNSHolding(s) in Company
16th Jan 20263:00 pmRNSHolding(s) in Company
14th Jan 202610:30 amRNSHolding(s) in Company
13th Jan 202610:30 amRNSHolding(s) in Company
13th Jan 20267:00 amRNSDirectorate change
19th Dec 202511:00 amRNSDirector/PDMR Shareholding
19th Dec 202511:00 amRNSDirector/PDMR Shareholding
5th Dec 202510:30 amRNSHolding(s) in Company
5th Dec 202510:30 amRNSHolding(s) in Company
26th Nov 20254:25 pmRNSHolding(s) in Company
28th Oct 202510:45 amRNSHolding(s) in Company
28th Oct 202510:45 amRNSHolding(s) in Company
27th Oct 202510:30 amRNSHolding(s) in Company
23rd Oct 202511:45 amRNSHolding(s) in Company
23rd Oct 20257:00 amRNSQ3 Trading Update
21st Oct 202510:00 amRNSHolding(s) in Company
14th Oct 202510:00 amRNSHolding(s) in Company
1st Oct 202510:30 amRNSBlock listing Interim Review
30th Sep 202510:30 amRNSCompletion of France Workwear business sale
25th Sep 20254:15 pmRNSDirector/PDMR Shareholding
24th Sep 20256:00 pmRNSDirector Declaration
26th Aug 202512:30 pmRNSInterim Dividend – Pence Sterling Amount Payable
7th Aug 202511:10 amRNSHolding(s) in Company
31st Jul 20257:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.